Gene expression profiling of circulating CD133+ cells of hepatocellular carcinoma patients associated with HCV infection
Conclusion KRT15 can be used to differentiate between circulating CD133+ cells from HCC group control group. However, further study may be needed to confirm on the protein level.
Source: Journal of the Egyptian National Cancer Institute - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Genetics | Hepatocellular Carcinoma | Liver Cancer | Stem Cell Therapy | Stem Cells | Study